The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that treat patients with reduced fat in the blood. They are commonly used to lower triglyceride and cholesterol levels and reduce fat associated with heart attacks and strokes. In this new experiment, the researchers found that they may also be used to treat certain blood cancers.
Binciken da aka yi a baya ya nuna cewa statins na inganta apoptosis (mutuwar kwayoyin halitta) a wasu nau'in ciwon daji, kuma wannan binciken ya nuna cewa suna iya amfani da su wajen magance wadannan cututtuka. A cikin wannan binciken, masu binciken sun gano cewa simvastatin yana haɓaka tasirin Venetoclax akan cutar sankarar lymphocytic na yau da kullun a cikin ƙirar linzamin kwamfuta. Yana taimakawa wajen rage lymphoma ta hanyar ƙara siginar apoptosis a cikin kwayoyin cutar kansa, yana haifar da ƙarin lokacin rayuwa. Sun kuma yi nuni da cewa, wannan binciken ya fi duk wani magani da aka bayar shi kadai.
The researchers were encouraged by the results of this study and began three clinical trials involving the testing of Venetoclax for the treatment of chronic lymphocytic leukemia, looking for data on patients who had received statins. They found that these patients responded better to cancer by 2.7 times than those who did not take statins.
Masu bincike sun ce idan statins suna da irin wannan tasiri a cikin mutane, miliyoyin mutane a duniya sukan yi amfani da su don rage matakan cholesterol. Baya ga rage kitse a cikin jini, an kuma nuna ba su da wani illa. Masu binciken sun yi imanin cewa ya kamata a gudanar da gwaje-gwaje na asibiti don sanin ko statins na iya inganta hasashen marasa lafiya da cutar sankarar bargo da sauran cututtukan jini.
